Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Societe Generale Downgrades AbbVie to Hold

Societe Generale Downgrades AbbVie to Hold

Societe Generale analyst Justin Smith downgrades AbbVie (NYSE:ABBV) from Buy to Hold.

byBenzinga Newsdesk

November 8, 2022

1 minute read

Societe Generale analyst Justin Smith downgrades AbbVie (NYSE:ABBV) from Buy to Hold.

Bloomin’ Brands Q4 Bottom-Line Exceeds Expectations; Hikes Dividend By 71%; Plans Stock Buyback

By Shivani Kumaresan

February 16, 2:36 PM

Bloomin’ Brands Inc (NASDAQ:BLMN) reported fourth-quarter FY22 sales growth of 4.6% year-on-year to $1.09 billion, missing the consensus of $1.12 billion.…

BLMN

News

Mainz Biomed Announces Addition of Eurofins GeLaMed to its Growing Network of Lab Partners

By Benzinga Newsdesk

May 3, 3:44 AM

Mainz Biomed NV (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that it has

MYNZ